Fabrice Cognasse: The EFS Is First and Foremost Part of a Medical Discipline – Transfusion
Fabrice Cognasse, Director of Research – Scientific Director at The EFS in Auvergne-Rhône-Alpes and INSERM, shared a post on LinkedIn:
”Two very enriching sessions today with the teams of the Bourg-en-Bresse site around the Scientific Department of the EFS AuRA / Inserm!
Fascinating exchanges, relevant questions and a strong conviction: the scientific approach is everywhere at the EFS.
It guides both our medico-technical activities and our support functions, in the service of quality, innovation and patients.
The EFS is first and foremost part of a medical discipline: transfusion.
A scientific heritage that dates back in particular to Jean-Baptiste Denis, a pioneer of the first transfusion experiments in the seventeenth century and a founding figure in the history of blood transfusion.
This scientific curiosity, this desire to understand, improve and innovate are fully shared by the teams – and it’s a real collective strength!
Thank you all for your warm welcome and the richness of the exchanges!”
Stay updated with Hemostasis Today.
-
Nov 12, 2026, 13:04Wuhan Thrombosis Congress 2026 – Bringing Global Experts Together – ISTH
-
Nov 12, 2026, 13:00Abdul Mannan: Factor IX Prophylaxis – Can Breakthrough Bleeding Still Occur?
-
Nov 12, 2026, 12:55Clara N.: A United Effort to Reduce the Burden of SCD in Uganda
-
Nov 12, 2026, 12:38Sophia Delicou: Greece and Cyprus Unite to Advance Thalassaemia and Sickle Cell Care
-
Nov 12, 2026, 12:36Wolfgang Miesbach: Three Cleavages, One Key to Factor VIII Activation
-
Nov 12, 2026, 12:04Yazan Abou-Ismail: Pleasure Discussing Factor 11 Inhibitors with Nashwa Abdulsalam at Heart Rhythm TV
-
Nov 12, 2026, 11:57Javed Anees: Asundexian – A New Era in Secondary Stroke Prevention
-
Nov 12, 2026, 10:30Nancy Di Salvo: Protecting Access to IVIG and SCIG – A Call for Continued EU Recognition
-
Nov 12, 2026, 10:28Ali Hammed: Should DOAC Use Exclude Patients From Thrombolysis After Ischemic Stroke?